Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
about
Metformin and its clinical use: new insights for an old drug in clinical practice.Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review.Linagliptin plus metformin: a pharmacokinetic and pharmacodynamic evaluation.Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme.Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes.
P2860
Beyond metformin: initiating combination therapy in patients with type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@en
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@nl
type
label
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@en
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@nl
prefLabel
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@en
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@nl
P2860
P356
P1433
P1476
Beyond metformin: initiating c ...... with type 2 diabetes mellitus.
@en
P2093
Jennifer D Goldman-Levine
P2860
P304
P356
10.1592/PHCO.31.12.44S
P407
P433
P577
2011-12-01T00:00:00Z